Feature

Research Reports

Overactive Bladder Health Care Burden in the US Long-Term Care Setting: A Retrospective Cohort Study

05/18/2021

Drishti Shah , PhD;

Jason Yeaw , MPH;

Amy Kincaid , MA;

Paul N. Mudd Jr., PharmD, MBA;

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Richard Stefanacci, DO, and colleagues describe and evaluate the population, treatment patterns, HCRU, and costs associated with overactive bladder in the in the US long-term care setting.

Richard Stefanacci, DO, and...

05/18/2021

Journal of Clinical Pathways

Research Reports

Assessing Clinician Attitudes and Beliefs Around Financial Toxicity Screening in Medical Oncology Clinic

05/17/2021

Errol J. Philip , PhD;

Lucky Ding ;

Sylvia T. Zhang , MS;

Tracy Kuo Lin , MSc, PhD;

Hala T. Borno , MD;

Nichole Legaspi ;

Sylvia Zhang, MS, and colleagues discuss the attitudes, motivation, and experiences of clinicians regarding screening for financial toxicity in a medical oncology clinical setting, identifying potential opportunities for future clinician-led...

Sylvia Zhang, MS, and colleagues...

05/17/2021

Journal of Clinical Pathways

Research Reports

Pediatric Sunscreen Coverage by Medicaid as a Primary Prevention Strategy to Reduce Melanoma Burden: A Cost-Effectiveness Analysis

04/22/2021

Christine T. Lauren , MD;

Richard D. Carvajal , MD;

Connor Stonesifer , BA;

Chin Hur , MD, MPH;

Robert Stern , MD;

Daniel C. Malone , RPh, PhD, FAMCP;

Larisa J. Geskin , MD;

Megan H. Trager , MD;

Dawn Queen , MD;

Abstract: Melanoma treatment costs continue to rise. Sunscreen is a photoprotective tool that may reduce the incidence of melanoma but can be cost prohibitive for lower socioeconomic populations. New York State...

...

04/22/2021

Journal of Clinical Pathways

Perspectives

Patient Voices in Value-Based Cancer Care: Priorities for the Biden Administration

04/22/2021

Jacqlyn Riposo , MBA;

Mark McClellan , MD, PhD;

Kimberly Westrich , MA;

Ethan Basch , MD, MSc;

Tom Valuck , MD, JD;

Theresa Schmidt , MA, PMP, CSPO;

Abstract: The Biden administration has an opportunity to prioritize patient perspectives in innovative value-based payment models for oncology by incorporating meaningful patient-reported measures (PRMs) and...

...

04/22/2021

Journal of Clinical Pathways

Research Report

Electronic Consultations for Subspecialists: A Potential Virtual Pathway for Patient Clinic Visits

03/15/2021

Kenneth R. Meehan , MD;

Joshua D. Hickman , MHA;

Megan M. Colgan , BA;

Michelle M. L'Heureux , MD, FACP;

Christopher H. Lowrey , MD;

Abstract: With the onset of the COVID pandemic, computer-assisted clinic visits and telemedicine have become a critical aspect of patient care. As a rural National Cancer Institute-designated cancer center, the...

...

03/15/2021

Journal of Clinical Pathways

Research Report

Clinical Pathways Utilization and Total Cost of Care for the Treatment of Prostate Cancer

02/22/2021

Ashley A. Durand , MS;

Peter A.S. Johnstone , MD;

Dana E. Rollison , PhD;

Sandra C. Stewart , CTR;

Dung-Tsa Chen , PhD;

Yaroslav Shtogun , PhD;

David C. Boulware , MS;

Julio M. Pow-Sang , MD;

Karen A. Sereday , MS;

Karen K. Fields , MD;

Tracy C. Simpson , RCIS, FSICP, RN;

Abstract: We analyzed adherence to multidisciplinary clinical pathways to understand the impact on the cost of care for patients with prostate cancer. Methods: A retrospective cohort design identified 560 patients...

...

02/22/2021

Journal of Clinical Pathways

Research Reports

The Impact of a Clinical Decision Support System for Advanced Gastric or Gastroesophageal Junction Cancer

12/16/2020

Anindya Chatterjee , PhD;

Astra M. Liepa , PharmD;

Marley Boyd , MS;

Scott Paulson , MD;

Kathleen M. Aguilar , MPH;

Lisa M. Hess , PhD;

Abstract: Gastric cancer treatment heterogeneity was assessed over successive updates of clinical pathways. Methods: Patient profiles, treatment patterns, and outcomes were assessed descriptively among adult patients...

...

12/16/2020

Journal of Clinical Pathways

From the Field

Feasibility of Transitioning to Virtual Multidisciplinary Thoracic Tumor Board

12/16/2020

Chelsea Jackson , RN;

Steven Kirtland , MD;

Erik Stiles , MSc;

David L. Coy , MD, PhD;

Michal Hubka , MD;

Joseph Rosales , MD;

Abstract: Delay in management of thoracic malignancies and lung nodules can result in poor clinical outcomes. Multidisciplinary tumor boards (MTBs) represent a standard of care that must evolve in the setting of...

...

12/16/2020

Journal of Clinical Pathways

From the Field

Update on the Evolution of The US Oncology Network’s Clinical Pathways Program

11/18/2020

Marcus A. Neubauer , MD;

Aimee Ginsburg , PharmD, BCPS;

Lalan Wilfong , MD;

Abstract: The National Comprehensive Cancer Network (NCCN) Guidelines are seen as the most comprehensive and most frequently updated cancer clinical practice guidelines available. Clinical pathways have a narrower...

...

11/18/2020

Journal of Clinical Pathways

Perspectives

Approaching Clinical Pathway Development as an Art

11/18/2020

Craig Ornstein , PhD, MA;

Seth Gordon , MBA;

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Abstract: In health care, rules and regulations are in place for good reason, but there is an art to integrating them into care effectively to benefit patients as well as the other stakeholders—clinically and...

...

11/18/2020

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Feature

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products